Sotera Health Free Cash Flow (FCF) History (SHC)
Sotera Health reported $149.2M in free cash flow for fiscal 2025, an increase of 230.81% from the previous fiscal year, with a free cash flow margin of 12.82%.
View full Sotera Health company overviewSotera Health free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $149.2M | $104.1M | +230.81% | +12.82% |
| 2024 | 2024-12-31 | $45.1M | $407.8M | — | +4.10% |
| 2023 | 2023-12-31 | −$362.7M | −$458.3M | — | −34.57% |
| 2022 | 2022-12-31 | $95.6M | −$83.8M | −46.72% | +9.52% |
| 2021 | 2021-12-31 | $179.4M | $112.3M | +167.42% | +19.26% |
| 2020 | 2020-12-31 | $67.1M | −$24.7M | −26.92% | +8.20% |
| 2019 | 2019-12-31 | $91.8M | — | — | +11.79% |
Sotera Health quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $42.0M | $15.9M | +60.56% | +13.08% |
| Q1 2026 | 2026-03-31 | −$16.7M | −$52.3M | — | −5.97% |
| Q4 2025 | 2025-12-31 | $52.4M | $62.6M | — | +17.27% |
| Q3 2025 | 2025-09-30 | $35.0M | −$26.1M | −42.71% | +11.24% |
| Q2 2025 | 2025-06-30 | $26.2M | $6.8M | +35.17% | +8.90% |
| Q1 2025 | 2025-03-31 | $35.6M | $60.8M | — | +13.99% |
| Q4 2024 | 2024-12-31 | −$10.2M | −$58.5M | — | −3.50% |
| Q3 2024 | 2024-09-30 | $61.1M | $71.2M | — | +21.39% |
| Q2 2024 | 2024-06-30 | $19.4M | $409.1M | — | +7.00% |
| Q1 2024 | 2024-03-31 | −$25.2M | −$14.1M | — | −10.15% |
| Q4 2023 | 2023-12-31 | $48.3M | $18.1M | +59.98% | +15.57% |
| Q3 2023 | 2023-09-30 | −$10.2M | −$38.9M | — | −3.86% |
| Q2 2023 | 2023-06-30 | −$389.7M | −$411.9M | — | −152.66% |
| Q1 2023 | 2023-03-31 | −$11.1M | −$25.6M | — | −5.05% |
| Q4 2022 | 2022-12-31 | $30.2M | $5.1M | +20.34% | +12.00% |
| Q3 2022 | 2022-09-30 | $28.8M | −$36.0M | −55.61% | +11.57% |
| Q2 2022 | 2022-06-30 | $22.2M | −$32.1M | −59.09% | +8.32% |
| Q1 2022 | 2022-03-31 | $14.4M | −$20.8M | −59.05% | +6.09% |
| Q4 2021 | 2021-12-31 | $25.1M | $23.1M | +1168.30% | +10.40% |
| Q3 2021 | 2021-09-30 | $64.8M | $29.0M | +80.83% | +28.66% |
| Q2 2021 | 2021-06-30 | $54.3M | $17.7M | +48.43% | +21.53% |
| Q1 2021 | 2021-03-31 | $35.2M | $42.5M | — | +16.60% |
| Q4 2020 | 2020-12-31 | $2.0M | — | — | +0.91% |
| Q3 2020 | 2020-09-30 | $35.9M | — | — | +17.92% |
| Q2 2020 | 2020-06-30 | $36.5M | — | — | +17.15% |
| Q1 2020 | 2020-03-31 | −$7.3M | — | — | −3.88% |
Sotera Health free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from $67.1M to $149.2M, a compound annual growth rate of 17.33%. Sotera Health's latest reported quarter, Q2 2026, generated $42.0M in free cash flow, an increase of 60.56% year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Sotera Health filings at SEC.gov ↗